May 02, 2013
BD Announces Results for 2013 Second Fiscal Quarter
|
April 26, 2013
BD Diagnostics Advances Commitment to a Fully Integrated Microbiology Solution with New Agreement
|
April 22, 2013
FDA Approves Second Drug in BD Simplist™ Prefilled Injectable Line of Products
|
April 17, 2013
New Gastrointestinal Tract Infections Assays Launch in Europe
|
April 10, 2013
BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS™ Passive Needle Guard
|
April 08, 2013
New Molecular Assay Provides Healthcare Facilities with a Simple, Efficient Way to Detect Dangerous Superbug
|
April 08, 2013
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
April 07, 2013
CML HealthCare Inc. to Install North America's First and World's Largest Fully Automated BD Kiestra™ Microbiology Platform
|
March 27, 2013
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
|
March 13, 2013
BD Announces Appointment of Dr. Ellen Strahlman as Chief Medical Officer and Senior Vice President, Research & Development
|
March 12, 2013
BD Acquires Cato Software Solutions
|
February 27, 2013
Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
|
February 27, 2013
BD to Present at Investor Healthcare Conferences
|
February 07, 2013
BD to Present at Investor Healthcare Conferences
|
February 05, 2013
BD Announces Results for 2013 First Fiscal Quarter
|
January 29, 2013
Catherine M. Burzik Elected as BD Director
|
January 29, 2013
BD Board Declares Dividend
|
January 23, 2013
BD Announces Webcast of Annual Meeting of Shareholders
|
January 15, 2013
BD PhaSeal™ System Receives Clearance from FDA Under Newly Created ONB Product Code
|
January 08, 2013
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
